The startup has developed a sensitive fluorescence platform that enhances the analytical sensitivity of fluorescence detection systems, enabling precise diagnostics in various applications. This technology allows users to achieve higher detection capabilities in environments with elevated electromagnetic fields, improving diagnostic accuracy and reliability.
Funding
Funding not disclosed
Founders
Product
Problem
Conventional fluorescence detection systems often lack the analytical sensitivity required for precise diagnostics, particularly in environments with electromagnetic interference. This limitation hinders accurate detection of target substances in biological samples, impacting the reliability of diagnostic results.
Solution
FIANOSTICS has developed the FluoBolt™ platform, a novel fluorescence-based immunoassay technology that enhances analytical sensitivity through metal-enhanced fluorescence (MEF). By utilizing plasmonic structures manufactured with Blu-ray technology, FluoBolt™ assays achieve up to 100-fold higher sensitivity compared to traditional methods. The platform supports one-step assays without enzyme substrates, enabling rapid and reliable detection of substances in biological samples. FluoBolt™ assays are designed for standard microtiter plate formats, ensuring compatibility with existing laboratory equipment and workflows. The technology is applied in both in-vitro diagnostics (IVD) and research use only (RUO) settings, offering solutions for clinical diagnostics, biomarker analysis, and custom assay development.
Target Audience
The primary target audience includes clinical researchers, diagnostic companies, and healthcare providers seeking high-sensitivity immunoassays for biomarker detection, routine diagnostics, and custom assay development.
Features
- Metal Enhanced Fluorescence (MEF) technology for >100-fold increase in analytical sensitivity
- One-step assays without the need for enzyme substrates
- Utilizes plasmonic structures manufactured with Blu-ray technology for reproducibility
- Compatible with standard 96-well microtiter plate readers
- Minimal sample volume required (10-30 µL)
- Multiplexing capabilities for simultaneous detection of multiple analytes
- Scalable assay formats (96, 384 well, slides)
- Option for optical QC of every surface